How can I find financial assistance for patients with Opdivo?
BMS Access Support ® can help identify financial assistance programs for eligible patients who have been prescribed OPDIVO and who need help managing the cost of treatment. The appropriate program will depend on the patient's coverage.
What is Opdivo used to treat?
OPDIVO ® (nivolumab) is a prescription medicine used to treat people with a type of skin cancer called melanoma to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery. It is not known if OPDIVO is safe and effective in children younger than 18 years of age.
Is Opdivo safe for a child under 18?
It is not known if OPDIVO is safe and effective in children younger than 18 years of age. For Patients With Metastatic Melanoma (3 of 12) OPDIVO® (nivolumab) is a prescription medicine used to treat people with a type of skin cancer called melanoma that has spread or cannot be removed by surgery (advanced melanoma).
What is Opdivo (nivolumab)?
OPDIVO® (nivolumab) is a prescription medicine used to treat people with liver cancer (hepatocellular carcinoma) after you have received treatment with Nexavar® (sorafenib). OPDIVO was approved based on response rate and how long patients’ responses lasted.
Is Opdivo expensive?
Depending on the dose, Opdivo can cost $6,580 per infusion. According to the manufacturer, more than 60 percent of patients pay only a quarter of this price or less with coverage from Medicare, Medicaid, or other insurance plans.
Does Bristol Myers Squibb have a patient assistance program?
The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) is an independent, charitable organization that helps eligible patients who need temporary help obtaining the medicines listed on this website.
How much does Opdivo and yervoy cost?
The combination of Yervoy (ipilumumab) and Opdivo (nivolumab) will cost more than $250,000 per year. Bristol-Myers Squibb is also testing the Yervoy/Opdivo combo for treatment of lung cancer.
What is OPDIVO used for?
A drug that binds to the protein PD-1 to help immune cells kill cancer cells better and is used to treat many different types of cancer. These include cancers that express the protein PD-L1 or that have certain mutations (changes) in genes involved in DNA repair.
How do I get Eliquis for $10 a month?
Eligible patients who present an activated Co-pay Card together with a valid prescription for ELIQUIS at participating pharmacies may pay as little as $10 per 30-day supply (up to 74 tablets for the first fill and up to 60 tablets for all subsequent fills) for up to 24 months, subject to a maximum annual benefit of ...
What can I do if I can't afford Eliquis?
Call Tap to call 1-855-ELIQUIS (354-7847) from Monday – Friday, 8 AM – 8 PM (ET). Live specialists are here to: Help you find out if ELIQUIS is covered by your insurance plan. Determine if you are eligible for assistance paying for ELIQUIS.
How much longer can you live with Opdivo and Yervoy?
According to 6.5 year data from CheckMate-067, median overall survival (OS) for patients with advanced melanoma was 72.1 months with Opdivo plus Yervoy, compared with 36.9 months for patients received Opdivo alone and 19.9 months for Yervoy monotherapy.
When should I stop using Opdivo?
If your doctor confirms you had a serious allergic reaction to Opdivo, they'll stop your Opdivo treatment and decide if another cancer treatment is right for you.
What is cost of an Opdivo treatment?
The cost for Opdivo intravenous solution (10 mg/mL) is around $1,247 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Is Opdivo better than chemotherapy?
Opdivo is the first PD-1 inhibitor to demonstrate superior OS and PFS in combination with chemotherapy when compared to chemotherapy alone in patients with gastric cancer, GEJ cancer or esophageal adenocarcinoma.
How quickly does Opdivo work?
How long does Opdivo take to work?Cancer Type (Trial name)Median Time to ResponseSquamous cell carcinoma of the head and neck (CheckMate-141)Opdivo: 2.1 months (range 1.8-7.4) vs Investigator's choice (methotrexate, docetaxel or cetuximab) : 2.0 (range 1.9-4.6)6 more rows
Does Opdivo shrink tumors?
Nivolumab (Opdivo) helps shrink tumors, helps patients with advanced melanoma to live longer and decreases the risk of the melanoma coming back after surgery. It is also approved for adjuvant therapy.
Is Eliquis made by Pfizer?
Sales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues in the latest reported quarter. Eliquis is an approved treatment to reduce the risk of stroke in patients with irregular heartbeat or atrial fibrillation.
What is simple fill?
Simplefill is a full-service prescription assistance company that researches, qualifies, and maintains patients' enrollment in all sources of assistance available to them.
Does Walgreens accept Eliquis co pay card?
Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Who makes Eliquis medication?
Brand Name: Eliquis® Generic Name: apixaban Manufacturer: Bristol-Myers Squibb Co. with nonvalvular atrial fibrillation. completing 6-12 months of standard anticoagulation for venous thromboembolism). Postoperative DVT prophylaxis for arthroplasty of the knee.
What is OPDIVO in combination with?
OPDIVO, in combination with YERVOY ® (ipilimumab), is indicated for the treatment of patients with unresectable or metastatic melanoma.
What is OPDIVO used for?
OPDIVO is indicated for the adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT). OPDIVO, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the treatment ...
What is odivo in cancer?
OPDIVO ® (nivolumab), in combination with YERVOY ® (ipilimumab), is indicated for the treatment of adults and pediatric patients 12 years and older with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan. This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
What is opdivo nivolumab?
OPDIVO ® (nivolumab) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
What is the name of the drug that is used to treat pleural mesothelioma?
OPDIVO ® (nivolumab), in combination with YERVOY ® (ipilimumab), is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma (MPM).
What is nivolumab used for?
OPDIVO ® (nivolumab) is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving OPDIVO.
Does opdivo cause liver toxicity?
OPDIVO in combination with cabozantinib can cause hepatic toxicity with higher frequencies of Grade 3 and 4 ALT and AST elevations compared to OPDIVO alone. Consider more frequent monitoring of liver enzymes as compared to when the drugs are administered as single agents. In patients receiving OPDIVO and cabozantinib, Grades 3 and 4 increased ALT or AST were seen in 11% of patients.
What is opdivo used for?
OPDIVO ® (nivolumab) is a prescription medicine used to treat people with cancer of the stomach (gastric), cancer where the esophagus joins the stomach (gastroesophageal junction), and in people with esophageal adenocarcinoma. OPDIVO may be used in combination with chemotherapy that contains fluoropyrimidine and platinum when your cancer cannot be ...
What is the name of the medicine that is used to treat pleural mesothelioma?
For adults newly diagnosed with malignant pleural mesothelioma (MPM) OPDIVO ® (nivolumab) is a prescription medicine used in combination with YERVOY ® (ipilimumab) as a first treatment for adults with a type of cancer that affects the lining of the lungs and chest wall called malignant pleural mesothelioma which cannot be removed by surgery.
What is nivolumab used for?
OPDIVO ® (nivolumab) is a prescription medicine used to treat people with head and neck cancer (squamous cell carcinoma) that has come back or spread and you have tried chemotherapy that contains platinum and it did not work or is no longer working.
What is the treatment for melanoma after surgery?
For people with melanoma after it and the affected lymph nodes have been removed by surgery to prevent it from coming back. OPDIVO ® (nivolumab) is a prescription medicine used to treat people with a type of skin cancer called melanoma to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by ...
Does opdivo work for bladder cancer?
For people with previously treated advanced bladder cancer (urothelial carcinoma) OPDIVO ® (nivolumab) is a prescription medicine used to treat people with bladder cancer (urothelial carcinoma) that has spread or grown and you have tried chemotherapy that contains platinum, and it did not work or is no longer working.
Is opdivo a prescription?
There is ongoing evaluation of clinical benefit of OPDIVO for this use. OPDIVO ® (nivolumab) is a prescription medicine used in combination with YERVOY ® (ipilimumab) to treat people with liver cancer (hepatocellular carcinoma) if you have previously received treatment with sorafenib.
Does opdivo work?
OPDIVO ® (nivolumab) is a prescription medicine used to treat people with a type of advanced stage lung cancer (called non-small cell lung cancer) that has spread or grown and you have tried chemotherapy that contains platinum, and it did not work or is no longer working.
Appeals Assistance
If the patient's insurer has denied coverage, the denial may be appealed. BMS Access Support may be able to assist by providing information about the appeals process.
Identification of Charitable Organizations
BMS Access Support may help to identify charitable organizations that may provide funding for eligible patients seeking financial assistance for prescription medication.
Available medicines
Find out if the medicine your doctor prescribed is available through the Bristol Myers Squibb Patient Assistance Foundation.
Eligibility
Complete a brief assessment to see if you might be eligible for assistance.
How to apply
We'll need some information from both you and your doctor to process your application.
